Pharmarise Holdings Balance Sheet Health
Financial Health criteria checks 5/6
Pharmarise Holdings has a total shareholder equity of ¥8.0B and total debt of ¥10.6B, which brings its debt-to-equity ratio to 132.8%. Its total assets and total liabilities are ¥26.4B and ¥18.5B respectively. Pharmarise Holdings's EBIT is ¥1.4B making its interest coverage ratio 24.6. It has cash and short-term investments of ¥5.2B.
Key information
132.8%
Debt to equity ratio
JP¥10.56b
Debt
Interest coverage ratio | 24.6x |
Cash | JP¥5.16b |
Equity | JP¥7.95b |
Total liabilities | JP¥18.47b |
Total assets | JP¥26.43b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 2796's short term assets (¥11.8B) exceed its short term liabilities (¥8.7B).
Long Term Liabilities: 2796's short term assets (¥11.8B) exceed its long term liabilities (¥9.7B).
Debt to Equity History and Analysis
Debt Level: 2796's net debt to equity ratio (67.9%) is considered high.
Reducing Debt: 2796's debt to equity ratio has reduced from 192.2% to 132.8% over the past 5 years.
Debt Coverage: 2796's debt is well covered by operating cash flow (26.8%).
Interest Coverage: 2796's interest payments on its debt are well covered by EBIT (24.6x coverage).